Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota + human intestinal fluid
- Development stage
- Unknown
- Lead developer
- Shanghai Tenth People's Hospital
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Rectal, Nasojejunal
01
Overview
This experimental combination therapy involves the administration of fecal microbiota (often prepared via a washing process to reduce pro-inflammatory debris) alongside human intestinal fluid (HIF) harvested from healthy donors. Developed by researchers at Shanghai Tenth People's Hospital, the treatment aims to address the severe gut dysbiosis and gastrointestinal symptoms frequently observed in children with Autism Spectrum Disorder (ASD). The human intestinal fluid is hypothesized to provide a supportive biochemical environment—rich in enzymes, bile acids, and antimicrobial peptides—that enhances the engraftment and functional activity of the transplanted microbiota, thereby modulating the gut-brain axis and potentially improving behavioral symptoms of autism.
- Other names
- FMT + HIFFecal microbiota transplantation with human intestinal fluidWashed microbiota transplantation + human intestinal fluid
Beyond the preview
Go deeper on fecal microbiota + human intestinal fluid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota + human intestinal fluid.